Tardive and withdrawal dyskinesia associated with haloperidol.
D000293:Adolescent; D000328:Adult; D001480:Basal Ganglia Diseases / Q000139:chemically induced / Q000209:etiology; D002090:Butyrophenones / Q000009:adverse effects; D004305:Dose-Response Relationship, Drug; D005260:Female; D006220:Haloperidol / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009069:Movement Disorders / Q000139:chemically induced* / Q000209:etiology; D011618:Psychotic Disorders / Q000188:drug therapy; D013375:Substance Withdrawal Syndrome / Q000209:etiology*; D013997:Time Factors
D002090:Butyrophenones; D006220:Haloperidol